Dividend - Normal or Special

[JFTECH] Interim Dividend on 11-Dec-2024

Announcement Date: 26-Nov-2024
Related Stock:
JFTECH
JF TECHNOLOGY BHD
Share Registrar:
JFTECH
JF TECHNOLOGY BHD
FY: 30-Jun-2025
Amount

RM 0.0025

  • Ex Date
    11-Dec-2024
  • Entitlement Date
    12-Dec-2024
  • Payment Date
    26-Dec-2024
Description
JF TECHNOLOGY BHD announced a quarterly dividend of RM 0.0025 per share. The dividend is payable on 26-Dec-2024, while the ex-date will be on 11-Dec-2024. This is equivalent to the previous dividend of RM 0.0025 per share, with ex-date of 13-Sep-2024 and paid to the shareholders on 02-Oct-2024.

Ann. Date Ex Date Amount Payment Date

About JF TECHNOLOGY BHD
JF Technology Bhd is an investment holding company, which engages in the manufacture, packaging, marketing, trading, and distribution of electronic products, components, and test probes. Its products include rigid style contact technology, high-current cantilever style, and manual actuator solutions. In addition, the firm engaged in design, development, custom manufacture, and sale of integrated circuit test sockets, interconnect, and test solutions and equipment for the semiconductor and electronics assembly markets. Geographically it operates in Malaysia, the United States, the Philippines, China, Taiwan, Japan, and internationally.

How to be entitled
To be entitled for any of the above, you need to purchase the shares one trading day before the ex-Date. You will not be entitled for the above if you purchase the shares on or after the ex-Date.

On ex-Date, the price will be adjusted to reflect the theoretical market price of the stock after the entitlement. You can sell the shares on / after ex-Date and still be entitled to the corporate exercise. The key is to purchase the shares before ex-Date.

How to apply
No application is needed. Shareholders that fulfill the requirement above will receive the dividend in their registered bank account on the payment date automatically.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment